Abstract
Chronic heart failure is a major cause of morbidity and mortality, but its prognosis remains poor. Vitamin D hormone has many extra-skeletal functions including a positive impact on the cardiovascular system, and has been proposed for mortality risk evaluation in heart failure patients. The aim of the present study was to evaluate vitamin D status in heart failure patients, measured by high performance liquid chromatography coupled with mass spectrometry and to correlate serum 25 hydroxy-vitamin D (25OHD) levels with functional (peak VO2%) and mortality (Metabolic Exercise Cardiac Kidney Index) heart failure parameters. We enrolled 261 consecutive patients diagnosed with heart failure; all patients underwent a comprehensive clinical and biochemical characterization, and serum 25OHD levels were measured by high performance liquid chromatography coupled with mass spectrometry. Cardiopulmonary test parameters and Metabolic Exercise Cardiac Kidney Index of mortality risk were measured in all patients. Serum 25OHD levels ranged between 2 and 45 ng/ml (mean 17 ± 9 ng/ml); most patients (87%) showed hypovitaminosis D, and 25% showed severe vitamin D deficiency (serum 25OHD < 10 ng/ml). Patients with 25OHD < 10 ng/ml had significantly lower cardiopulmonary test VO2/kg, peak VO2% and significantly higher N-terminalproBrain natriuretic peptide and Metabolic Exercise Cardiac Kidney Index, than patients with 25OHD > 10 ng/ml. Patients with peak VO2% < 50% showed significantly lower 25OHD compared to those with peak VO2% > 50%. There was a significant, positive correlation (r = 0.16, p = 0.008) between 25OHD levels and peak VO2%, and an inverse correlation with Metabolic Exercise Cardiac Kidney Index (r = −0.21, p < 0.001), even when adjusted for age, Body Mass Index, MDRD, N-terminalproBrain natriuretic peptide. In conclusion, our findings show that vitamin D levels are associated with functional and mortality heart failure prognosis parameters.
Similar content being viewed by others
References
D. Aune, A. Sen, T. Norat, I. Janszky, P. Romundstad, S. Tonstad, L.J. Vatten, Body mass index, abdominal fatness, and heart failure incidence and mortality: a systematic review and dose-response meta-analysis of prospective studies. Circulation 133, 639–649 (2016)
Y.C. Li, J. Kong, M. Wei, Z.F. Chen, S.Q. Liu, L.P. Cao, 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J. Clin. Invest. 110, 229–238 (2002)
Y.C. Li, Vitamin D regulation of the renin-angiotensin system. J. Cell. Biochem. 88(2), 327–331 (2003)
A. Rahman, S. Hershey, S. Ahmed, K. Nibbelink, R.U. Simpson, Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice. J. Steroid Biochem. Mol. Biol. 103, 416–419 (2007)
S.S. Schleithoff, A. Zittermann, G. Tenderich, H.K. Berthold, P. Stehle, R. Koerfer, Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am. J. Clin. Nutr. 83, 754–759 (2006)
M.F. Holick, N.C. Binkley, H.A. Bischoff-Ferrari, C.M. Gordon, D.A. Hanley, R.P. Heaney, M.H. Murad, C.M. Weaver, Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96, 1911–1930 (2011)
M.F. Holick, T.C. Chen, Vitamin D deficiency: a worldwide problem with health consequences. Am. J. Clin. Nutr. 87, 1080S–1086S (2008)
J.F. Aloia, Clinical review: the 2011 report on dietary reference intake for vitamin D: where do we go from here? J. Clin. Endocrinol. Metab. 96, 2987–2996 (2011)
R.A. Bouillon, J.H. Auwerx, W.D. Lissens, W.K. Pelemans, Vitamin D status in the elderly: Seasonal substrate deficiency causes 1,25-dihydroxycholecalciferol deficiency. Am. J. Clin. Nutr. 45, 755–763 (1987)
T. Skaaby, L.L.N. Husemoen, C. Pisinger, T. Jørgensen, B.H. Thuesen, M. Fenger, A. Linneberg, Vitamin D status and incident cardiovascular disease and all-cause mortality: a general population study. Endocrine 43, 618–625 (2013)
L. Wang, Y. Song, J.E. Manson, S. Pilz, W. März, K. Michaëlsson, A. Lundqvist, S.K. Jassal, E. Barrett-Connor, C. Zhang, C.B. Eaton, H.T. May, J.L. Anderson, H.D. Sesso, Circulating levels of 25hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ. Cardiovasc. Qual. Outcomes 5, 819–829 (2012)
S.T. Lugg, P.A. Howells, D.R. Thickett, Optimal vitam in D supplementation levels for cardiovascular disease protection. Dis. Markers 2015, 1–10 (2015)
S.E. Judd, V. Tangpricha, Vitamin D deficiency and risk for cardiovascular disease. Am. J. Med. Sci. 338, 40–44 (2009)
B. Kestenbaum, R. Katz, I. De Boer, A. Hoofnagle, M.J. Sarnak, M.G. Shlipak, N.S. Jenny, D.S. Siscovick, Vitamin D, Parathyroid hormone, and cardiovascular events among older adults. J. Am. Coll. Cardiol. 58, 1433–1441 (2011)
G. Muscogiuri, V. Nuzzo, A. Gatti, A. Zuccoli, S. Savastano, C. Di Somma, R. Pivonello, F. Orio, A. Colao, Hypovitaminosis D: a novel risk factor for coronary heart disease in type 2 diabetes? Endocrine 51(2), 268–273 (2015)
T. Skaaby, L.L.N. Husemoen, C. Pisinger, T. Jørgensen, B.H. Thuesen, K. Rasmussen, M. Fenger, P. Rossing, A. Linneberg, Vitamin D status and 5-year changes in urine albumin creatinine ratio and parathyroid hormone in a general population. Endocrine 44, 473–480 (2013)
J. Kendrick, G. Targher, G. Smits, M. Chonchol, 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis 205, 255–260 (2009)
J.M. El-Khoury, E.Z. Reineks, S. Wang, Progress of liquid chromatography-mass spectrometry in measurement of vitamin D metabolites and analogues. Clin. Biochem. 44, 66–76 (2011)
G.D. Carter, Accuracy of 25-hydroxyvitamin D assays: confronting the issues. Curr. Drug. Targets 12, 19–28 (2011)
B.W. Hollis, Measuring 25-hydroxyvitamin D in a clinical environment: challenges and needs. Am. J. Clin. Nutr. 88, 507S–510S (2008)
J.O. O’Neill, J.B. Young, C.E. Pothier, M.S. Lauer, Peak oxygen consumption as a predictor of death in patients with heart failure receiving beta-blockers. Circulation 111, 2313–2318 (2005)
R. Arena, J. Myers, J. Abella, M.A. Peberdy, D. Bensimhon, P. Chase, M. Guazzi, Development of a ventilatory classification system in patients with heart failure. Circulation 115, 2410–2417 (2007)
J. Crespo, C.J. Lavie, R.V. Milani, Y.E. Gilliland, H.M. Patel, H.O. Ventura, Metabolic parameters derived from cardiopulmonary stress testing for prediction of prognosis in patients with heart failure: the ochsner experience. Ochsner J. 9, 46–53 (2009)
U. Corrà, P. Agostoni, A. Giordano, G. Cattadori, E. Battaia, R. La Gioia, A.B. Scardovi, M. Emdin, M. Metra, G. Sinagra, G. Limongelli, R. Raimondo, F. Re, M. Guazzi, R. Belardinelli, G. Parati, D. Magrì, C. Fiorentini, M. Cicoira, E. Salvioni, M. Giovannardi, F. Veglia, A. Mezzani, D. Scrutinio, A. Di Lenarda, R. Ricci, A. Apostolo, A.M. Iorio, S. Paolillo, P. Palermo, M. Contini, C. Vassanelli, C. Passino, P. Giannuzzi, M.F. Piepoli, The metabolic exercise test data combined with Cardiac and Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study. Int. J. Cardiol. 203, 1067–1072 (2016)
V. Carubelli, M. Metra, U. Corrà, D. Magrì, C. Passino, C. Lombardi, D. Scrutinio, M. Correale, G. Cattadori, M.F. Piepoli, E. Salvioni, M. Giovannardi, R. Raimondo, M. Cicoira, R. Belardinelli, M. Guazzi, G. Limongelli, F. Clemenza, G. Parati, A.B. Scardovi, A. Di Lenarda, M. Bussotti, R. La Gioia, P. Agostoni, Exercise performance is a prognostic indicator in elderly patients with chronic heart failure–application of metabolic exercise cardiac kidney indexes score. Circ. J. 79, 2608–2615 (2015)
P. Ponikowski, A.A. Voors, S.D. Anker, H. Bueno, J.G.F. Cleland, A.J.S. Coats, V. Falk, J.R. González-Juanatey, V.P. Harjola, E.A. Jankowska, M. Jessup, C. Linde, P. Nihoyannopoulos, J.T. Parissis, B. Pieske, J.P. Riley, G.M.C. Rosano, L.M. Ruilope, F. Ruschitzka, F.H. Rutten, P. Van Der Meer, 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 37, 2129–2200m (2016)
S.A. Hsu, J. Soldo, M. Gupta, Evaluation of two automated immunoassays for 25-OH vitamin D: comparison against LC-MS/MS. J. Steroid Biochem. Mol. Biol. 136, 139–145 (2013)
H.W. Moon, J.H. Cho, M. Hur, J. Song, G.Y. Oh, C.M. Park, Y.M. Yun, J.Q. Kim, Comparison of four current 25-hydroxyvitamin D assays. Clin. Biochem. 45, 326–330 (2012)
K.D. Cashman, K.G. Dowling, Z. Škrabáková, M. Gonzalez-Gross, J. Valtueña, S. De Henauw, L. Moreno, C.T. Damsgaard, K.F. Michaelsen, C. Mølgaard, R. Jorde, G. Grimnes, G. Moschonis, C. Mavrogianni, Y. Manios, M. Thamm, G.B.M. Mensink, M. Rabenberg, M.A. Busch, L. Cox, S. Meadows, G. Goldberg, A. Prentice, J.M. Dekker, G. Nijpels, S. Pilz, K.M. Swart, N.M. Van Schoor, P. Lips, G. Eiriksdottir, V. Gudnason, M.F. Cotch, S. Koskinen, C. Lamberg-Allardt, R.A. Durazo-Arvizu, C.T. Sempos, M. Kiely, Vitamin D deficiency in Europe: pandemic? Am. J. Clin. Nutr. 103, 1033–1044 (2016)
E.A. Yetley, C.M. Pfeiffer, R.L. Schleicher, K.W. Phinney, D.A. Lacher, S. Christakos, J.H. Eckfeldt, J.C. Fleet, G. Howard, A.N. Hoofnagle, S.L. Hui, G.L. Lensmeyer, J. Massaro, M. Peacock, B. Rosner, D. Wiebe, R.L. Bailey, P.M. Coates, A.C. Looker, C. Sempos, C.L. Johnson, M.F. Picciano, NHANES monitoring of serum 25-hydroxyvitamin D: a roundtable summary. J. Nutr. 140, 2030S–2045S (2010)
G. Sarno, G. Daniele, G. Tirabassi, A.O. Chavez, O.O. Ojo, F. Orio, H. Kahleova, G. Balercia, W.B. Grant, P. De Rosa, A. Colao, G. Muscogiuri, The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes. Endocrine 50, 568–574 (2015)
A. Di Nisio, L. De Toni, E. D’Addato, M.R. Pizzo, P. Sabatino, C. Foresta, 25-Hydroxyvitamin D insufficiency discriminates cardiovascular risk factors accumulation in peri-pubertal boys undergoing overweight screening. Endocrine 53, 530–537 (2016)
R.S. Boxer, A.M. Kenny, V.K. Cheruvu, M. Vest, J.J. Fiutem, I.I. Piña, Serum 25-hydroxyvitamin D concentration is associated with functional capacity in older adults with heart failure. Am. Heart J. 160, 893–899 (2010)
A. Kaul, S. Gläser, A. Hannemann, C. Schäper, M. Nauck, S.B. Felix, T. Bollmann, R. Ewert, N. Friedrich, Vitamin D is associated with cardiopulmonary exercise capacity: results of two independent cohorts of healthy adults. Br. J. Nutr. 25, 1–9 (2015)
A.J. Coats, The “muscle hypothesis” of chronic heart failure. J. Mol. Cell. Cardiol. 28, 2255–2262 (1996)
H.C.J.P. Janssen, M.M. Samson, H.J.J. Verhaar, Vitamin D deficiency, muscle function, and falls in elderly people. Am. J. Clin. Nutr. 75, 611–615 (2002)
R. Boland, A. Norman, E. Ritz, W. Hasselbach, Presence of a 1,25-dihydroxy-vitamin D3 receptor in chick skeletal muscle myoblasts. Biochem. Biophys. Res. Commun. 128, 305–311 (1985)
H.A. Bischoff, M. Borchers, F. Gudat, U. Duermueller, R. Theiler, H.B. Stähelin, W. Dick, In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem. J. 33, 19–24 (2001)
H.C.J.P. Janssen, M.M. Samson, H.J.J. Verhaar, Muscle strength and mobility in vitamin D-insufficient female geriatric patients: a randomized controlled trial on vitamin D and calcium supplementation. Aging Clin. Exp. Res. 22, 78–84 (2010)
S. Nesby-O’Dell, K.S. Scanlon, M.E. Cogswell, C. Gillespie, B.W. Hollis, A.C. Looker, C. Allen, C. Doughertly, E.W. Gunter, B.A. Bowman, Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988–1994. Am. J. Clin. Nutr. 76, 187–192 (2002)
A.C. Looker, C.L. Johnson, D.A. Lacher, C.M. Pfeiffer, R.L. Schleicher, C.T. Sempos, Vitamin D status: United States, 2001-2006. NCHS Data Brief 127, 1–8 (2011)
L.M.G. Meems, P. van der Harst, W.H. van Gilst, R.A. de Boer, Vitamin D biology in heart failure: molecular mechanisms and systematic review. Curr. Drug. Targets 12, 29–41 (2011)
P. Agostoni, U. Corra, G. Cattadori, F. Veglia, R. La Gioia, A. Sardovii, F. Re, M. Guazzi, R. Belardinelli, D. Scrutinio, R. Ricci, L. Bettari, A. Lenarda, L. Pastormerlo, G. Pacileo, R. Vaninetti, A. Apostolo, A. Iorio, S. Paolillo, P. Palermo, M. Contini, M. Confalonieri, P. Gianuzzi, A. Passantino, L. Cas, M. Piepoli, C. Passino, Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis. Int. J. Cardiol. 167, 2710–2718 (2013)
I. Gotsman, A. Shauer, D.R. Zwas, Y. Hellman, A. Keren, C. Lotan, D. Admon, Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; Vitamin D supplementation improves outcome. Eur. J. Heart Fail. 14, 357–366 (2012)
E. Belen, A. Sungur, M.A. Sungur, Vitamin D levels predict hospitalization and mortality in patients with heart failure. Scand. Cardiovasc. J. 50(1), 1–23 (2015)
W.-L. Jiang, H.-B. Gu, Y.-F. Zhang, Q.-Q. Xia, J. Qi, J.-C. Chen, Vitamin D supplementation in the treatment of chronic heart failure: a meta-analysis of randomized controlled trials. Clin. Cardiol. 39(1), 55–61 (2015)
A. Zittermann, S.S. Schleithoff, R. Koerfer, Vitamin D insufficiency in congestive heart failure: why and what to do about it? Heart Fail. Rev. 11, 25–33 (2006)
A. Zittermann, S. Schulze Schleithoff, G. Tenderich, H.K. Berthold, R. Körfer, P. Stehle, Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J. Am. Coll. Cardiol. 41, 105–112 (2003)
E. Christ, A. Linka, G. Junga, M. Odermatt, H. Steinert, W. Kiowski, C. Schmid, Bone density and laboratory parameters of bone metabolism in patients with terminal heart disease. Schweiz. Med. Wochenschr. 126, 1553–1559 (1996)
I. Garcia Delgado, L. Gil-Fraguas, E. Robles, G. Martinez, F. Hawkins, Clinical factors associated with bone mass loss previous cardiac transplantation. Med. Clin. (Barc.) 114, 761–764 (2000)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent:
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Saponaro, F., Marcocci, C., Zucchi, R. et al. Hypovitaminosis D in patients with heart failure: effects on functional capacity and patients’ survival. Endocrine 58, 574–581 (2017). https://doi.org/10.1007/s12020-017-1282-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-017-1282-9